Palliative sedation for children at end of life: a retrospective cohort study

Yang Chen1, Jianjun Jiang2, Wei Peng1

  • 1Department of Palliative Medicine, West China School of Public Health and West China Fourth Hospital, Sichuan University, No. 18, Section 3, South Renmin Road, Wuhou District, Chengdu, Sichuan province, China.

BMC Palliative Care
|April 27, 2022
PubMed

Insights

Palliative sedation effectively manages complex symptoms in children at the end of life. This therapy improves symptom control without increasing hospitalization duration, offering crucial support during critical care.

Area of Science:

  • Pediatric Palliative Care
  • End-of-Life Symptom Management
  • Sedative Therapy

Background:

  • Palliative sedation involves intentionally reducing consciousness to relieve refractory symptoms.
  • Research on palliative sedation specifically for children is limited.
  • This study investigates symptom control and risks associated with sedative therapy in pediatric end-of-life care.

Purpose of the Study:

  • To evaluate the effectiveness of palliative sedation in managing symptoms in children nearing end of life.
  • To compare symptom relief, survival time, and hospitalization duration between sedated and non-sedated pediatric patients.
  • To identify potential risks and benefits of palliative sedation in a pediatric palliative care setting.

Main Methods:

  • A single-center, retrospective cohort study was conducted.
  • Pediatric patients who died in the Palliative Medicine Department were divided into two groups: palliative sedation (Group A) and non-palliative sedation (Group B).
  • Outcomes including symptom relief, survival time, and last hospitalization time were compared between the groups.

Main Results:

  • A total of 41 children died during the study period; 24 received palliative sedation (Group A) and 17 did not (Group B).
  • Group A experienced more complex symptoms (p=0.013) and demonstrated higher overall symptom relief (p=0.041) compared to Group B.
  • While pain relief rates and opioid doses did not differ significantly, Group A had a longer survival time after diagnosis (p=0.047), with similar hospitalization lengths.

Conclusions:

  • Palliative sedation is an effective method for controlling complex and painful symptoms in children at the end of life.
  • Sedative therapy in pediatric palliative care does not appear to shorten hospitalization time.
  • The findings support the use of palliative sedation for symptom management in pediatric end-of-life care.
Abstract

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
216
Continuing Care01:25

Continuing Care

Continuing care describes the variety of health, personal, and social services provided over a prolonged period. The need for continuing care is increasing because people are living longer. Many people do not have families or others to care for them. Continuing care is mainly for patients who are disabled, functionally dependent, or suffering from a terminal disease. It is available within institutional settings or in homes. Examples include nursing centers or facilities, assisted living,...
1.6K
Sedatives and Hypnotics: Overview01:23

Sedatives and Hypnotics: Overview

Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
731
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
773
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
551
Sedatives and Hypnotics Drugs: Miscellaneous Agents01:17

Sedatives and Hypnotics Drugs: Miscellaneous Agents

Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
253